B lymphocytes from stable renal transplant patients do not respond to exogenous lymphokines: comparison of azathioprine and cyclosporin treated patients.
Weissgarten
J
J
Division of Nephrology, University of Toronto, Toronto Western Hospital, Ontario, Canada.
Ng
C
C
Freidman
E
E
Cardella
C J
CJ
D000917:Antibody Formation / Q000187:drug effects; D001379:Azathioprine / Q000627:therapeutic use*; D001402:B-Lymphocytes / Q000187:drug effects / Q000276:immunology*; D003524:Cyclosporins / Q000627:therapeutic use*; D006085:Graft Survival; D006801:Humans; D066298:In Vitro Techniques; D007376:Interleukin-2 / Q000494:pharmacology*; D015847:Interleukin-4; D007378:Interleukins / Q000494:pharmacology*; D016030:Kidney Transplantation; D008213:Lymphocyte Activation / Q000187:drug effects; D011241:Prednisone / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000494:pharmacology
D003524:Cyclosporins; D007376:Interleukin-2; D007378:Interleukins; D011994:Recombinant Proteins; D015847:Interleukin-4; D001379:Azathioprine; D011241:Prednisone